Literature DB >> 12087538

Nosocomial bloodstream infections in Finnish hospitals during 1999-2000.

O Lyytikäinen1, J Lumio, H Sarkkinen, E Kolho, A Kostiala, P Ruutu.   

Abstract

Prospective laboratory-based surveillance in 4 Finnish hospitals during 1999-2000 identified 1477 cases of nosocomial bloodstream infection (BSI), with an overall rate of 0.8 BSIs per 1000 patient-days. Of BSI cases, 33% were in patients with a hematological malignancy and 15% were in patients with a solid malignancy; 26% were in patients who had undergone surgery preceding infection. Twenty-six percent of BSIs were related to intensive care, and 61% occurred in patients with a central venous catheter. Sixty-five percent of the 1621 causative organisms were gram positive, 31% were gram negative, and 4% were fungi. The most common pathogens were coagulase-negative staphylococci (31%), Escherichia coli (11%), Staphylococcus aureus (11%), and enterococci (6%). Methicillin resistance was detected in 1% of S. aureus isolates and vancomycin resistance in 1% of enterococci. The 7-day case-fatality ratio was 9% and was highest for infections caused by Candida (21%) and enterococci (18%). The overall rate of nosocomial BSIs was similar to rates in England and the United States, but S. aureus, enterococci, and fungi were less common in our study, and the prevalence of antibiotic resistance was lower.

Entities:  

Mesh:

Year:  2002        PMID: 12087538     DOI: 10.1086/340981

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

Review 1.  [Endotoxins. Pathogenetic meaning of sepsis].

Authors:  H Rensing
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Infections and bacterial colonization during cytotoxic therapy in patients with acute leukemia.

Authors:  O Perola; T Nousiainen; J Pentikäinen; A Laatikainen; M L Katila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

4.  What do central venous catheter-associated bloodstream infections have to do with bundles?g.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

5.  Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray.

Authors:  Berit E E Cleven; Maria Palka-Santini; Jörg Gielen; Salima Meembor; Martin Krönke; Oleg Krut
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

6.  Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.

Authors:  Agnès Lefort; Xavière Panhard; Olivier Clermont; Paul-Louis Woerther; Catherine Branger; France Mentré; Bruno Fantin; Michel Wolff; Erick Denamur
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

7.  Risk factors of nosocomial bloodstream infections in surgical intensive care unit.

Authors:  Xing Zhang; Meng-Meng Tong; Miao-Zun Zhang; Hui-Peng Zhu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  A 7-year study of bloodstream infections in an English children's hospital.

Authors:  James W Gray
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

9.  The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999-2014.

Authors:  Keiju S K Kontula; Kirsi Skogberg; Jukka Ollgren; Asko Järvinen; Outi Lyytikäinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-17       Impact factor: 3.267

10.  Carriage of methicillin-resistant Staphylococci and their SCCmec types in a long-term-care facility.

Authors:  Salha Ibrahem; Saara Salmenlinna; Anni Virolainen; Anne-Marie Kerttula; Outi Lyytikäinen; Henrik Jägerroos; Markku Broas; Jaana Vuopio-Varkila
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.